Home / Drug shortages / Chlorothiazide Oral Suspension

Chlorothiazide Oral Suspension — FDA Drug Shortage

To Be Discontinued — Salix Pharmaceuticals, a division of Bausch Health US, LLC

The FDA lists a drug shortage record for Chlorothiazide Oral Suspension (oral suspension) from Salix Pharmaceuticals, a division of Bausch Health US, LLC with status To Be Discontinued. The shortage was first posted on 02/10/2026.

Shortage Details

Status
To Be Discontinued
Company
Salix Pharmaceuticals, a division of Bausch Health US, LLC
Package NDC
65649-311-12
Dosage Form
Oral Suspension
Presentation
Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12)
Initial Posting
02/10/2026
Revised Date

FDA data resources